Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - OTHER LIABILITIES
Other Liabilities AKBA - Akebia Therapeutics, Inc.
49 M
LAST VALUE
-40.66%
2 YEAR CAGR
8.50%
5 YEAR CAGR
5659.83%
10 YEAR CAGR